| Sassan Soltani, MD | |
|
50 Alessandro Place, Suite 410, Pasadena, CA 91105-3954 | |
| (626) 793-7114 | |
| (626) 793-7679 |
| Full Name | Sassan Soltani |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 34 Years |
| Location | 50 Alessandro Place, Pasadena, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649244104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | G73313 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huntington Memorial Hospital | Pasadena, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Healthcare Partners | 2163606807 | 185 |
News Archive
In 1844, multiple myeloma was first treated with a rhubarb pill and an infusion of orange peel. Since then, more than 15 drugs have earned FDA approval to treat multiple myeloma and with so many options, a major question has become what cocktail and sequence is best?
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
A new study suggests that people who have an alcoholic drink or two a day may have a lower risk of becoming obese than either teetotalers or heavy drinkers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
› Verified 4 days ago
| Entity Name | Genesis Healthcare Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548567498 PECOS PAC ID: 2163606807 Enrollment ID: O20110405000433 |
News Archive
In 1844, multiple myeloma was first treated with a rhubarb pill and an infusion of orange peel. Since then, more than 15 drugs have earned FDA approval to treat multiple myeloma and with so many options, a major question has become what cocktail and sequence is best?
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
A new study suggests that people who have an alcoholic drink or two a day may have a lower risk of becoming obese than either teetotalers or heavy drinkers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sassan Soltani, MD 50 Alessandro Pl, Suite 410, Pasadena, CA 91105-3149 Ph: (626) 793-7114 | Sassan Soltani, MD 50 Alessandro Place, Suite 410, Pasadena, CA 91105-3954 Ph: (626) 793-7114 |
News Archive
In 1844, multiple myeloma was first treated with a rhubarb pill and an infusion of orange peel. Since then, more than 15 drugs have earned FDA approval to treat multiple myeloma and with so many options, a major question has become what cocktail and sequence is best?
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection. The forthcoming trial will also compare the effects of two different doses of the new drug.
A new study suggests that people who have an alcoholic drink or two a day may have a lower risk of becoming obese than either teetotalers or heavy drinkers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that sanofi-aventis has initiated a Phase I clinical trial with SAR650984, an investigational antibody that targets cancer cells expressing the CD38 protein antigen. This event triggers a $1 million milestone payment to ImmunoGen.
› Verified 4 days ago
Ms. Kimberly Anne Shriner, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 50 Alessandro Pl, Suite 360, Pasadena, CA 91105 Phone: 626-793-6133 Fax: 626-793-6135 | |
Praneet Kalkat, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 960 E Green St Ste 105, Pasadena, CA 91106 Phone: 626-304-0782 Fax: 626-310-0552 | |
Gargi H Upadhyaya, M.D. Gastroenterology Medicare: May Accept Medicare Assignments Practice Location: 1121 Arden Rd, Pasadena, CA 91106 Phone: 626-256-4673 | |
Lu Jiao, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 301 S Fair Oaks Ave, Suite 300, Pasadena, CA 91105 Phone: 626-795-7556 | |
Kristin J Karlyn, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1044 S Fair Oaks Ave Ste 101, Pasadena, CA 91105 Phone: 626-734-7870 Fax: 626-593-6550 | |
Dr. Glenn David Littenberg, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 630 S Raymond Ave, Suite 240, Pasadena, CA 91105 Phone: 626-449-9920 Fax: 626-578-7366 | |
Dr. Robert E Ladines, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1515 N Fair Oaks Ave, Pasadena, CA 91103 Phone: 626-798-1111 Fax: 626-345-1901 |